Stocksigma LogoStocksigma Logo

Brooks Laboratories Board to Consider Q2 FY27 Financial Results on 7th Nov'26

Brooks Laboratories Limited announced that its Board of Directors will meet on 7th Nov'26 to consider and approve the unaudited standalone and consolidated

Brooks Laboratories Board to Consider Q2 FY27 Financial Results on 7th Nov'26

Brooks Laboratories Ltd 路 Others (Uncategorized) 路 03 Nov 2026, 5:34 pm

Brooks Laboratories Board to Consider Q2 FY27 Financial Results on 7th Nov'26 Brooks Laboratories Limited announced that its Board of Directors will meet on 7th Nov'26 to consider and approve the unaudited standalone and consolidated financial results, along with the Limited Review Report, for the quarter and half-year ended 30th Sep'26. Additionally, the insider trading window, closed since 1st Oct'26, will reopen 48 hours following the declaration of the financial results.

Original exchange filing (PDF)

More announcements from Brooks Laboratories Ltd

All Brooks Laboratories Ltd announcements